Francis A. Farraye, MD, MSc
Professor of Medicine
M.D., 1982, Albert Einstein College of Medicine Bronx, NY
MSc Epidemiology, 2001, Harvard School of Public Health, Boston, MA
General field of research:
Clinical Research in Gastroenterology
Affiliations other than medicine:
Evans Center for Interdisciplinary Biomedical Research
Section of Gastroenterology, Boston Medical Center, 85 East Concord Street
Phone: (617) 638-8339
Fax: (617) 638-6529
Inflammatory Bowel Disease; Crohn’s Disease; Ulcerative Colitis; Colon Polyps; Ileal Pouch Anal Anastomosis; Vitamin D
Summary of research interest:
Dr. Farraye’s clinical interests are in the care of patients with inflammatory bowel disease, the management of colon polyps and colorectal cancer, as well endoscopy in patients after bariatric surgery. He is studying Vitamin D absorption in patients with IBD, the management and diagnosis of dysplasia and cancer in patients with IBD, and predictors of pouchitis after ileal pouch-anal anastomosis (IPAA). In the area of colorectal cancer, he is examining the role of hyperplastic polyps as an alternative pathway in the development of colorectal cancer.
Miller HL, Farraye FA, Coukos JA, Howard LA, Stucchi AF, Holick MF, Becker JM. Vitamin D deficiency and insufficiency are common in ulcerative colitis patients after ileal pouch-anal anastomosis. Inflamm Bowel Dis. 2012 Jan 24. doi: 10.1002/ibd.22890. [Epub ahead of print].
Coukos JA, Howard LA, Weinburg JM, Becker JM, Stucchi AF, Farraye FA. ASCA-IgG and CBir antibodies are associated with the development of postoperative Crohn’s disease and fistulae following ileal pouch-anal anastomosis. Dig Dis Sci. 2012 Jun;57(6):1544-53. Epub 2012 Feb 7.
Gillespie E, Leeman SE, Watts LA, Coukos JA, O’Brien MJ, Cerda SR, Farraye FA, Stucchi AF, Becker JM. Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer. J Crohns Colitis. 2012 Aug 22. [Epub ahead of print]
Kwah J. Ditelberg JS, Farraye FA. Gender and location of CRC in IBD: Implications for surveillance protocols. Inflamm Bowel Dis. 2012 Apr 16. doi: 10.1002/ibd.22984.
Sinclair JA, Wasan SK, Farraye FA. Health maintenance in the inflammatory bowel disease patient. Gastroenterol Clin North Am. 2012 Jun;41(2):325-37. doi: 10.1016/j.gtc.2012.01.006. Epub 2012 Feb 24. Review.
Berg AM, Kelly CP, Farraye FA. Clostridium difficile Infection in the Inflammatory Bowel Disease Patient. Inflamm Bowel Dis. 2013 Jan;19(1):194-204. doi: 10.1002/ibd.22964.